The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
The officer fired after the boy, who is being treated in hospital, failed to raise his hands when told to.
A pair of cyclists made the shocking discovery of a baby at the bottom of a drain in Australia.
A weather warning is in place across the south-east with heavy rainfall expected. Elsewhere there will be plenty of sunshine around.